Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00683631 · ClinicalTrials.gov registry record
TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC)
A clinical trial, sponsored by University of Louisville.
- Completed
- Registry status
- 183
- Enrollment target
NCT00683631 is a clinical trial that has completed, run by University of Louisville. The registered enrollment target is 183 participants.
The verdict
NCT00683631 has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- 183 participants
- Enrollment target
Study Summary
The purpose of this protocol is to provide access to Therasphere treatment for patients with liver tumors.
Interventions
- OTHER TheraSphere HUD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 183 participants |
| Start Date | 2004-01 |
| Est. Completion | 2021-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00683631
The ClinicalTrials.gov registry entry for NCT00683631 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 183 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TheraSphere HUD is the first listed.
NCT00683631 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00683631 about?
NCT00683631 is a clinical study titled "TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC)". The purpose of this protocol is to provide access to Therasphere treatment for patients with liver tumors.
What is the current status of trial NCT00683631?
This trial is currently completed. The enrollment target is 183 participants. The study started on 2004-01. Estimated completion is 2021-04-01.
What interventions are being tested in trial NCT00683631?
The interventions under investigation include: TheraSphere HUD (OTHER).
Who is sponsoring clinical trial NCT00683631?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.